Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BeOne Medicines AG
OTC:BEIGF
BeOne Medicines AG
OTC:BEIGF
Price:
21.946
USD
Market Cap:
$2.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BeOne Medicines AG
OTC:BEIGF
|
CH |
|
R
|
Reach PLC
F:MRR
|
UK |
|
Alstom SA
OTC:AOMFF
|
FR |
|
Newfoundland Discovery Corp
F:M4K
|
CA |
|
E
|
Electromagnetic Geoservices ASA
F:E2M
|
NO |
Wall St Price Targets
BEIGF Price Forecast
Based on 8 analysts
Based on 8 analysts
+48% Upside
from
$21.946
today
BeOne Medicines AG (BEIGF)’s 12-month stock price forecast through October 2027 has a consensus target of $32.403, implying 48% upside. The forecast is based on price targets from 8 Wall Street analysts.
BEIGF Analyst Rating
No ratings yet
No ratings yet
BeOne Medicines AG Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BEIGF's stock price target?
Price Target
32.403
USD
32.403
USD
According to Wall Street analysts, the average 1-year price target for BEIGF is 32.403 USD with a low forecast of 27.042 USD and a high forecast of 41.774 USD.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
61%
61%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next -3 years is 61%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.
